These findings demonstrate that PEG-N109C-vcMMAE and N109C-vcMMAE could specifically deliver MMAE to target tumor tissue, where the internalized and accumulated MMAE started killing TRAIL-resistant and -sensitive tumor cells. Here, TNFSF10 is linked to neoplasm.